NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
NovelStem International Net Income (Quarterly) : -0.0858M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0858M |
| March 31, 2026 | -0.055M |
| December 31, 2025 | -0.0893M |
| September 30, 2025 | -0.0774M |
| June 30, 2025 | 2.754M |
| March 31, 2025 | -0.2072M |
| December 31, 2024 | -1.792M |
| September 30, 2024 | -2.464M |
| June 30, 2024 | -0.3026M |
| March 31, 2024 | -0.3033M |
| December 31, 2023 | 0.0166M |
| September 30, 2023 | -1.096M |
| June 30, 2023 | -2.875M |
| March 31, 2023 | -0.2688M |
| December 31, 2022 | -0.2762M |
| September 30, 2022 | -0.2953M |
| December 31, 2013 | -1.626M |
| September 30, 2013 | 8.211M |
| June 30, 2013 | -0.043M |
| March 31, 2013 | -0.2887M |
| December 31, 2012 | 4.811M |
| September 30, 2012 | -2.316M |
| June 30, 2012 | -1.349M |
| March 31, 2012 | -0.6101M |
| December 31, 2011 | -0.1754M |
| Date | Value |
|---|---|
| September 30, 2011 | -5.580M |
| June 30, 2011 | 0.167M |
| March 31, 2011 | -1.713M |
| December 31, 2010 | -1.260M |
| September 30, 2010 | -0.8157M |
| June 30, 2010 | 0.045M |
| March 31, 2010 | -0.7645M |
| December 31, 2009 | -0.5598M |
| September 30, 2009 | -0.7877M |
| June 30, 2009 | -4.797M |
| March 31, 2009 | -0.095M |
| December 31, 2008 | -6.272M |
| September 30, 2008 | -1.899M |
| June 30, 2008 | -0.6923M |
| March 31, 2008 | -3.125M |
| December 31, 2007 | -2.179M |
| September 30, 2007 | -2.133M |
| June 30, 2007 | -1.452M |
| March 31, 2007 | -3.070M |
| December 31, 2006 | -1.195M |
| September 30, 2006 | -2.051M |
| June 30, 2006 | -1.212M |
| March 31, 2006 | -2.690M |
| December 31, 2005 | -1.381M |
| September 30, 2005 | -2.509M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Summit Therapeutics, Inc. | -215.70M |
| Kezar Life Sciences, Inc. | -5.756M |
| Protara Therapeutics, Inc. | -21.67M |
| Clene, Inc. | -13.42M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0858M |
| EPS Diluted (Quarterly) | -0.0017 |
| Enterprise Value | 2.190M |
| Earnings Yield | -67.37% |
| Normalized Earnings Yield | -68.42 |